Back
BridgeBio Pharma, Inc. 10K Form
Buy
60
BBIO
BridgeBio Pharma, Inc.
Last Price:
$74.79
Seasonality Move:
-0.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBIO News And Ratings
See the #1 stock for the next 7 days that we like better than BBIO
BBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $221.9M |
|---|---|
| Cash Flow: | $-112.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-10.04 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.18690 |
|---|---|
| Net Income (TTM): | $-805.7M |
| Gross Margin: | $214.3M |
| Return on Equity: | 0% |
| Return on Assets: | -88.65% |
BridgeBio Pharma, Inc. Earnings Forecast
Key BridgeBio Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for BBIO is 96.60%.
-
The Selling, General & Administrative Expenses for BBIO have been equal to 130.21% of Gross Profit Margin.
-
The Research & Development expenses have been 228.24% of Revenue.
-
The Net Earning history of BBIO is -244.86% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
BridgeBio Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBIO |
| CUSIP: | 10806X |
| Website: | bridgebio.com |
Debt
| Debt-to-Equity Ratio: | -1.4 |
|---|---|
| Current Ratio: | 3.88 |
| Quick Ratio: | 3.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBIO Technical Analysis vs Fundamental Analysis
Buy
60
BridgeBio Pharma, Inc. (BBIO)
is a Buy
Is BridgeBio Pharma, Inc. a Buy or a Sell?
-
BridgeBio Pharma, Inc. stock is rated a BuyThe current BridgeBio Pharma, Inc. [BBIO] share price is $74.76. The Score for BBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.